Browsing Tag
anti-CD20 therapy
2 posts
Why anti-CD20 competition in multiple sclerosis is shifting toward real-world performance data
Discover why real-world data is reshaping anti-CD20 competition in MS and what it means for TG Therapeutics, Inc.’s BRIUMVI strategy. Read more.
How real-world evidence and pediatric studies may determine BRIUMVI’s ceiling in relapsing multiple sclerosis
Find out how real-world data and pediatric studies could define the long-term ceiling for TG Therapeutics’ BRIUMVI in relapsing multiple sclerosis.